A nurse is caring for a client who is taking sucralfate. Which of the following outcomes indicates a therapeutic effect of the medication?

A. "Prevention of opportunistic infections": Sucralfate is not an antimicrobial agent. It does not have a role in preventing infections. Instead, it works by forming a protective barrier over ulcers in the gastrointestinal tract, which helps in healing rather than preventing infections. B. "Improvement of impaired vision": Sucralfate has no impact on vision. It is specifically used for gastrointestinal issues, such as ulcers and gastritis, and does not affect visual acuity or conditions related to vision. C. "Alleviate Helicobacter pylori": While sucralfate helps protect the stomach lining, it does not directly treat Helicobacter pylori infection. Treatment of H. pylori typically involves antibiotics and proton pump inhibitors, not sucralfate. D. "Relief of gastrointestinal pain": Sucralfate works by forming a protective coating over ulcers, which helps to relieve gastrointestinal pain caused by ulcers or irritation in the stomach lining. This outcome indicates a therapeutic effect of the medication.